Kalkofen Donald A.
Insider CIK 1771066 · PTGX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PTGX Protagonist Therapeutics, | A Award deriv | 2022-02-15 | 2022-02-17 | 45,000 | — | $0 | 45,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2022-02-15 | 2022-02-17 | 7,500 | — | $0 | 18,521 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2021-02-26 | 2021-02-26 | 55,000 | — | $0 | 55,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2021-02-26 | 2021-02-26 | 7,500 | — | $0 | 10,386 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2020-02-28 | 2020-02-28 | 55,000 | — | $0 | 55,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | P Buy | 2019-12-03 | 2019-12-03 | 562 | $5.09 | $2.9K | 1,175 | SEC↗ |
| PTGX Protagonist Therapeutics, | P Buy | 2019-12-03 | 2019-12-03 | 613 | $5.10 | $3.1K | 613 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2019-05-31 | 2019-06-03 | 100,000 | — | $0 | 100,000 | SEC↗ |